2023-506572-27-00Active, not recruitingPhase 1
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY OF CLN-049 FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 28 Aug 2026
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 97 (estimated)
- First submitted
- 10 Aug 2023
- Start date
- 12 Jan 2024
- Lead sponsor
- Florentine Cullinan Corp.
- Diseases
- Acute myeloid leukemia
- EU CT number
- 2023-506572-27-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 97
- 11 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (11)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medizinische Hochschule Hannover | Hanover | Germany | Active, not recruiting |
| Universitaetsklinikum Leipzig Aor | Leipzig | Germany | Active, not recruiting |
| Klinikum der Universitaet Muenchen AöR | Munich | Germany | Active, not recruiting |
| Universitaetsklinikum Regensburg AöR | Regensburg | Germany | Active, not recruiting |
| Universitaetsklinikum Tuebingen AöR | Tuebingen | Germany | Active, not recruiting |
| Hospital San Pedro De Alcántara | Cáceres | Spain | Active, not recruiting |
| Hospital Universitario Fundación Jiménez Díaz | Madrid | Spain | Active, not recruiting |
| Clinica Universidad de Navarra | Madrid | Spain | Active, not recruiting |
| Clínica Universidad de navarra | Pamplona | Spain | Active, not recruiting |
| University Hospital Virgen Del Rocio S.L. | Sevilla | Spain | Active, not recruiting |
| Hospital Universitario Y Politecnico La Fe | Valencia | Spain | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.